Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma

Gynecologic Oncology

Volumn 62, Issue 1, 1996, Pages 33-41

  Van Driel, Willemien J ^a   Tjiong, Ming Y ^a   Hilders, Carina G J M ^a   Trimbos, Baptist J ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA;

EID: 0030200694     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0186     Document Type: Article

References (57)

1. 1. Feldman, M., and Eisenbach, L. MHC class I genes controlling the metastatic phenotype of tumor cells, Semin. Cancer Biol. 2, 337-346 (1991).
2. 2. McMichael, A. J., and Bodmer, W. F. Cancer surveys: A new look at tumour immunology, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1992).
3. 3. Tweddel, G., Heller, P., Cunnane, M, Multhaupt, H., and Roth, K. The correlation between HIV seropositivity, cervical dysplasia, and HIV subtypes 6/11, 16/18, 31/33/35, Gynecol. Oncol. 52, 161-164 (1994).
4. 4. Tomita, Y., Nishiyama, T., Fujiwara, M., and Sato, S. Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer, Br. J. Cancer 62, 354-359 (1990).
5. 5. Gatti, R. A., and Good, R. A. Occurrence of malignancies in immunodeficiency disease: A literature review, Cancer 28, 89-91 (1971).
6. 6. Starzl, T. E., and Penn, I. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy, Transplant. Rev. 7, 112-145 (1971).
7. 7. Schneider, V., Kay, S., and Lee, H. M. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasm of the cervix, Acta Cytol. 27, 220-224 (1983).
8. 8. Penn, I. Some contributions of transplantation to our knowledge of cancer, Transplant. Proc. 12, 676-680 (1980).
9. 9. Penn, I. Tumor incidence in human allograft recipients, Transplant. Proc. 11, 1047-1051 (1979).
10. 10. Stahl, R. E., Friedman-Kien, A., Dubin, R., Marmor, M., and Zolla-Pazner, S. Immunological abnormalities in homosexual men: Relationship of Kaposi's sarcoma, Am. J. Med. 73, 171-178 (1982).
11. 11. Freed, S. Z., Halperin, J. P., and Gordon, M. Idiopathic regression of metastasis from renal carcinoma, J. Urol. 118, 538 (1977).
12. 12. Ravenswaay Claasen, H. H., Kluin, P. M., and Fleuren, G. J. Tumor infiltrating cells in human cancer, Lab. Invest. 67, 166-174 (1992).
13. 13. Hilders, C. G. J. M., Houbiers, J. G. A., van Ravenswaay Claasen, H. H., Veldhuizen, R. W., and Fleuren, G. J. Association between HLA-expression and infiltration of immune cells in cervical carcinoma, Lab. Invest. 69, 651-659 (1993).
14. 14. Hilders, C. G. J. M., Ras, L., Van Eendenburg, J. D. H., Nooyen, Y., and Fleuren, G. J. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma, Int. J. Cancer 57, 805-813 (1994).
15. 15. Mackensen, A., Carcelain, G., Viel, S., Raynai, M., Michalaki, H., Triebel, F., Bosq, J., and Hercend, T. Direct evidence to support the immunosurveillance concept in a human regressive melanoma, J. Clin. Invest. 93, 1397-1402 (1994).
16. 16. Schendel, D. J., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Riethmüller, G., and Segurado, O. G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes, J. Immunol. 151, 4209-4220 (1993).
17. 17. Resnick, R. M., Cornelissen, M. T., Wright, D. K., Eichmger, G. H., Fox, H. S., ter Schegget, J., and Manos, M. M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers, J. Natl. Cancer Inst. 82, 1477 (1990).
18. 18. zur Hausen, H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers, Cancer Res. 49, 4677-4681 (1989).
19. 19. McCance, D. J., Campion, M. J., Clarkson, P. K., Chester, P. M., Jenkins, D., and Singer, A. Prevalence of human papillomavirus type 16 DNA sequence in cervical intraepithelial neoplasia and invasive carcinoma of the cervix, Br. J. Obstet. Gynaecol. 92, 1101-1105 (1985).
20. 20. Syrjänen, K. J. Human papillomavirus lesions in association with cervical dysplasias and neoplasias, Obstet. Gynecol. 62, 617-624 (1983).
21. 21. Chen, L., Thomas, K. E., Hu, S. L., Hellström, I., and Hellström, K. E. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen, Proc. Natl. Acad. Sci. USA 88, 110-114 (1991).
22. 22. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitopecontaining peptide protects against a tumor induced by human papillomavirus type 16-transformed cells, Eur. J. Immunol. 23, 2242-2249 (1993).
23. 23. Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz-Cabello, F., and Stern, P. L. Natural history of HLA expression during tumour development, Immunol. Today 14, 491-498 (1993).
24. 24. Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H. G., Foster, L., and Kärre, K. Association of class I major histocompatibility heavy and light chains induced by viral peptides, Nature 340, 443-448 (1989).
25. 25. Browning, M. J., and Bodmer, W. F. MHC antigens and cancer: implications for T-cell surveillance, Curr. Opin. Immunol. 4, 613-618 (1992).
26. 26. Glew, S. S., Duggan-Keen, M., Cabrera, T., and Stern, P. L. HLA class II antigen expression in human papilloma virus-associated cervical cancer, Cancer Res. 52, 4009-4016 (1992).
27. 27. Hilders, C. G. J. M., Houbiers, J. G. A., Krul, E. J. T., and Fleuren, G. J. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma, Am. J. Clin. Pathol. 101, 5-12 (1994).
28. 28. Torres, L. M., Cabrera, T., Concha, A., Oliva, M. R., Ruiz-Cabello, F., and Garrido, F. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix, Tissue Antigens 41, 65-71 (1993).
29. 29. Connor, M. E., and Stern, P. L. Loss of MHC class-I expression in cervical carcinomas, Int. J. Cancer 46, 1029-1034 (1990).
30. 30. Blaustein, A. Blaustein's pathology of the female genital tract, Springer Verlag, New York (1987).
31. 31. Edwards, J. H. HL-A and disease. The detection of associations, J. Immunogen. 1, 249-257 (1974).
32. 32. Moore, M. Natural immunity to tumours-Theoretical predictions and biological observations, Br. J. Cancer 52, 147-152 (1985).
33. 33. Bröcker, E. B., Siter, L., Brüggen, J., Ruiter, D. J., Macher, E., and Sorg, C. Phenotypic dynamics of tumor progression in human malignant melanoma, Int. J. Cancer 36, 29-35 (1985).
34. 34. van Duinen, S. G., Ruiter, D. J., Broecker, E. B., van der Velde, A., Sorg, C., Welvaart, K., and Ferrone, S. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma, Cancer Res. 48, 1019-1025 (1988).
35. 35. Durrant, L. G., Ballantyne, K. C., Armitage, N. C., Robins, R. A., Marksman, R., Hardcastle, J. D., and Baldwin, R. W. Quantification of MHC antigen expression on colorectal tumours and its association with tumour progression, Br. J. Cancer 56, 425-432 (1987).
36. 36. van den Ingh, H. F., Ruiter, D. J., Griffioen, G., van Muijen, G. N. P., and Ferrone, S. HLA antigens in colorectal tumours-Low expression of HLA class I antigens in mucinous colorectal carcinomas, Br. J. Cancer 55, 125-130 (1987).
37. 37. Mattijssen, V., de Mulder, P. H. M., Schalkwijk, L., Manni, J. J., van't Hof-Grootenboer, B., and Ruiter, D. J. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites, Int. J. Cancer 6(suppl.), 95-100 (1991).
38. 38. Kabawat, S. E., Bast, R. C., Welch, W. R., Knapp, R. C., and Bhan, A. K. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms, Int. J. Cancer 32, 547-554 (1983).
39. 39. Concha, A., Cabrera, T., Ruiz-Cabello, F., and Garrido, F. Can't the HLA phenotype be used as a prognostic factor in breast carcinomas? Int. J. Cancer 6,(Suppl.), 146-154 (1991).
40. 40. Wintzer, H. O., Benzing, M., and von Kleist, S. Lacking prognostic significance of β2-microglobulin, MHC class I and class II antigen expression in breast carcinomas, Int. J. Cancer 62, 289-295 (1990).
41. 41. Kast, W. M., Brandt, R. M. P., Drijfhout, J. W., and Melief, C. J. M. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2, J. Immunother. 14, 115-120 (1993).
42. 42. Kast, W. M., Brandt, R. M. P., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. M., and Sette, A. The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins, J. Immunol. 152, 3904-3912 (1994).
43. 43. zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer, Virology 184, 9-13 (1991).
44. 44. Ljunggren, H. G., Kärre In search of the 'missing self': MHC molecules and NK cell recognition, Immunol. Today 11, 237-244 (1990).
45. 45. Restifo, N. P., Kawakami, Y., Marincola, F., Shamamian, P., Taggarse, A., Esquivel, F., and Rosenberg, S. A. Molecular mechanisms used by tumors to escape immune recognition: Immunogenetherapy and the cell biology of major histocompatibility complex class I, J. Immunother. 14, 182-190 (1993).
46. 46. Cromme, F. V., Airey, J., Heemels, M. T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J. L. M., and Walboomers, J. M. M. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas, J. Exp. Med. 179, 335-340 (1994).
47. 47. Neefjes, J. J., Momburg, F., and Hämmerling, G. J. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter, Science 261, 769-771 (1993).
48. 48. Halloran, P. F., Autenried, P., Ramassar, V., Urmson, J., and Cockfield, S. Local T cell responses induce widespread MHC expression, J. Immunol. 148, 3837-3846 (1992).
49. 49. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., London, R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes, J. Exp. Med. 170, 827-845 (1989).
50. 50. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., and Ziegler, A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens -New tools for genetic analysis, Cell 14, 9-20 (1978).
51. 51. Brodsky, M, Bodmer, W. F., and Parham, P. Characterization of a monoclonal anti-beta-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens, Eur. J. Immunol. 9, 536-545 (1979).
52. 52. Stam, N. J., Spits, H., and Ploegh, H. L. Monoclonal antibodies against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products, J. Immunol. 137, 2299-2306 (1986).
53. 53. Parham, P., and Brodsky, M. Partial purification and some properties of BB7.2: A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28, Hum. Immunol. 3, 277-299 (1981).
54. 54. Berger, A. E., Davis, J. E., and Cresswell, P. Monoclonal antibody to HLA-A3, Hybridoma 1, 87-90 (1982).
55. 55. Watson, A. J., DeMars, R., Trowbridge, I. S., and Bach, F. H. Detection of a novel human class II HLA antigen, Nature 304, 358-361 (1983).
56. 56. Radka, S. F., Kostyu, D. D., and Amos, D. B. A monoclonal antibody against the HLA-Bw6 epitope, J. Immunol. 128, 2804-2806 (1982).
57. 57. Rofstad, E. K., Wahl, A., Hystad, M. E., Nesland, J. M., and Stokke, T. Establishment in monolayer culture and characterization of four human melanoma cell lines, Virchows Arch. 60, 189-197 (1991).